Glycomic Therapeutics Market Trends 2025–2029: Forecasts for Key Growth Segments

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Glycomic Therapeutics Market Expected To Expand Between 2025 And 2029?

The glycomic therapeutics market has expanded considerably in recent years. This market is expected to increase from $164.71 billion in 2024 to $189.51 billion by 2025, achieving a compound annual growth rate (CAGR) of 15.1%. The expansion observed historically is due to factors such as increased understanding of glycan importance, the rise in chronic diseases, the development of new drugs for rare conditions, and improved collaborations in glycomics research.

The glycomic therapeutics market size is anticipated to experience substantial growth in the upcoming years. It is projected to expand to $359.62 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 17.4%. This projected growth can be attributed to several factors including the expanding understanding of glycan biology, the rise of precision medicine approaches, increasing interest in immunotherapy, enhanced funding for rare diseases research, and the emergence of glycan biomarkers. Significant trends during this forecast period are expected to include the widening application of glycomics in oncology, the use of glycoengineering for improving therapeutic proteins, the integration of glycomics into immuno-oncology, the role of glycomics in rare and genetic disorders, and regulatory considerations pertaining to glycomic drugs.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11894&type=smp

What Are The Drivers Pushing New Developments In The Glycomic Therapeutics Market?

The rising incidence of diabetes is anticipated to propel the expansion of the glycomic therapeutics market. This chronic health condition impairs the body’s capacity to manage blood sugar (glucose) levels. Notably, alterations in glycans are observed in individuals with diabetes, potentially leading to insulin resistance and various metabolic irregularities. Furthermore, distinct glycan patterns serve as indicators for diagnosing the condition, forecasting its advancement, and evaluating the effectiveness of treatments. For example, data from the IDF Diabetes Atlas, a comprehensive global resource based in Belgium, indicated in March 2022 that the worldwide prevalence of diabetes is forecast to grow from 643 million in 2030 to 783 million by 2045, representing an increase of 140 million cases. Consequently, the growing prevalence of diabetes is fueling the growth of the glycomic therapeutics market.

What Are The Primary Types Of Segments Analyzed In The Glycomic Therapeutics Market?

The glycomic therapeuticsmarket covered in this report is segmented –

1) By Class: Isolated; Synthetic

2) By Structures: Glycoproteins; Targeting Sialic Acid; Proteoglycans; Targeting Glycosaminoglycans; Glycosylphosphatidylinositol (GPI)-Anchored Proteins And Heparin Based Glycans; Targeting Glycosphingolipids; Other Structures

3) By Mode Of Action: Inhibits Neuraminidase; Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate; Erythropoietin And Enzyme Replacement Therapy (ERT); Tissue Plasminogen Activator; Inhibits Glucosylceramide Synthase; Interleukin 1, 2 And 3; Beta And Gamma Interferons; Other Mode Of Action

4) By Indications: Thrombosis And Chemoprophylaxis; Anemia; Anti-Adhesive And Anti-Inflammatory; Cataracts; Gaucher’s Disease; Mps-1 And IV; Cancer; Alzheimer’s Disease; Influenza Type A And B; Other Indications

Subsegments:

1) By Isolated: Natural Glycans; Glycan Derivatives; Glycoproteins

2) By Synthetic: Chemically Synthesized Glycans; Recombinant Glycans; Glycopeptides

What Trends Are Expected To Drive The Glycomic Therapeutics Market?

A significant trend emerging in the glycomic therapeutics market is product innovation. Leading firms within the glycomic therapeutics sector are concentrating on creating novel technological and inventive solutions to enhance their market standing. As an illustration, in April 2022, Glenmark Pharmaceuticals Limited, an India-based pharmaceutical company dedicated to discovering advanced therapies, introduced a unique fixed-dose combination (FDC) involving a DPP4 inhibitor (Dipeptidyl Peptidase 4 inhibitor), Teneligliptin, combined with Pioglitazone. This combination aims to enhance glycemic control and diminish insulin resistance among type 2 diabetes patients.

Who Are The Core Companies Influencing The Glycomic Therapeutics Market Landscape?

Major companies operating in the glycomic therapeutics market include F Hoffmann-La Roche Ltd., Bayer AG, Sanofi SA, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Merck KGaA, ICON plc, Agilent Technologies Inc., AMS Bio, Shimadzu Corporation, Waters Corporation, Bruker Corporation, BioMarin Pharmaceutical Inc., Bio Techne Corp., Promega Corporation, Halozyme Therapeutics Inc., Takara Bio Inc., Vector Laboratories, New England Biolabs Inc., Protalix Biotherapeutics Inc., Genovis AB, Ray Biotech Life Inc., IEC Group, Ludger Ltd, Z Biotech LLC, Alzheon Inc., GlycoMar Limited

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/glycomic-therapeutics-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The Glycomic Therapeutics Market?

North America was the largest region in the glycomic therapeutics in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the glycomic therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Glycomic Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=11894&type=smp

Browse Through More Reports Similar to the Global Glycomic Therapeutics Market 2025, By The Business Research Company

Blood Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-cancer-drugs-global-market-report

Cancer Biologics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report

Rituximab Biosimilar Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rituximab-biosimilar-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795